To be specific, tumor growth, M2 infiltration, and JAK2/STAT3 pathway activation induced by macrophages undergoing treatment of HCC cell‐derived exosomes were all compromised when the macrophages were treated with exosomes derived from HCC cells underexpressing PSMA5. The gene discussed is JAK2; the disease is neoplasm.